Devin Mangold, MD
Foot and Ankle Surgery · Fresno, CANPI 1326427444
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Cornerstone Medical Associates, Inc. at 41.7% of the total. Reporting peaked in 2023 at $3,586 and has fallen 99.4% since, to $23 in 2025.
Across 101 payments — averaging $74.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cornerstone Medical Associates, Inc.$3K
- Arthrex$2K
- Medical Device Business Services, Inc.$1K
- Stryker$613
- Johnson & Johnson$227
- Paragon 28, Inc.$152
- plus $274 from 3 others
Across 2 payments — averaging $10,000 each. An ownership or investment interest held by the physician or an immediate family member.
- Lazurite Inc.$20K
What the payments were for
- Travel & lodging$3,54147%
- Food & beverage$2,79237%
- Education$1,20016%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cornerstone Medical Associates, Inc. | 12 | $3,144 |
| Arthrex | 24 | $1,648 |
| Medical Device Business Services, Inc. | 11 | $1,474 |
| Stryker(2 entities) | 8 | $613 |
| Johnson & Johnson | 2 | $227 |
| Paragon 28, Inc. | 40 | $152 |
| Exactech, Inc. | 2 | $133 |
| Zimmer Biomet | 1 | $124 |
| Bioventus LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIS$1,325
- ATTUNE$1,325
- TRAUMA$170
- STAR$148
- VA-LCP PLATES & SCREWS$125
- Fusion Plate$124
- INFINITY$122
- TFN ADVANCED$102
- VANTAGE$100
How this compares
$7,533 in reported general payments places this provider in the 80th percentile of 1,126 foot and ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 62 | $191 |
| Hydroxyzine Pamoate | 38 | $114 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Fresno
- Eric GizaSacramento$3.6M
- Thomas HarrisPasadena$3M
- Thomas ChangSanta Rosa$2M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
- Andrew HsuOrange$456K
- Eric TanLos Angeles$447K
- Joseph ParkBurbank$387K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.